Last reviewed · How we verify
NCT03576456
Sedative Premedication in Coronary Angiography
NA trial testing Alprazolam 0.5 mg in Coronary Angiography in 264 participants. Status unknown.
1 January 2020
Quick facts
| Lead sponsor | Universitair Ziekenhuis Brussel |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 264 |
| Start date | 1 January 2019 |
| Primary completion | 1 January 2020 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Alprazolam 0.5 mg — full drug profile →
- Placebo Oral Tablet — full drug profile →
Conditions studied
- Coronary Angiography — all drugs for Coronary Angiography →
- Sedative Premedication — all drugs for Sedative Premedication →
Sponsor
Universitair Ziekenhuis Brussel — full company profile →
Who can join
Adults 18 to 99, any sex, with Coronary Angiography or Sedative Premedication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of the possible positive effect of sedative premedication prior to coronary angiography in regards to pain and anxiety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03576456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alprazolam 0.5 mg
Trials testing the same drug.
- NCT01745562 — Bioequivalence Trial of Alprazolam 0.5 mg Tablets · Phase 1 · completed
Other recruiting trials for Coronary Angiography
Currently open trials in the same condition.
- NCT04982419 — Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial · Phase 2, PHASE3 · recruiting
Other Universitair Ziekenhuis Brussel trials
Trials by the same sponsor.
- NCT07536230 — Deep Learning Framework for Continuous Depth of Anesthesia Forecasting · not yet recruiting
- NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
- NCT07289984 — Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders and · NA · not yet recruiting
- NCT06923813 — Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calo · NA · recruiting
- NCT07401004 — Effect of Blink-Based Training on Cancer Detection in Colorectal Polyp Images by Medical Students/Non GI-trainees · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03576456 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitair Ziekenhuis Brussel
- Last refreshed: 12 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03576456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing